Journal of Gastroenterology

, Volume 45, Issue 2, pp 171–178

Gallstones increase the prevalence of Barrett’s esophagus

  • Juntaro Matsuzaki
  • Hidekazu Suzuki
  • Keiko Asakura
  • Yoshimasa Saito
  • Kenro Hirata
  • Toru Takebayashi
  • Toshifumi Hibi
Original Article—Alimentary Tract

Abstract

Purpose

Bile and acid exposures are thought to be major risk factors for Barrett’s esophagus in Western countries. The association of gallstones with Barrett’s esophagus has not been fully evaluated. The present study was designed as a case-control study for determining the possible factors associated with endoscopically suspected esophageal metaplasia (ESEM), defined as an endoscopic finding suggestive of Barrett’s esophagus, in Japanese patients.

Methods

A total of 528 patients with ESEM were allocated to the case group, while 528 age- and gender-matched patients without ESEM were allocated to the control group. Findings on esophagogastroduodenoscopy and clinical background factors were compared using a multivariate logistic regression model.

Results

The presence of gallstones and hiatus hernia and the severity of gastric mucosal atrophy were independently associated with the presence of ESEM [odds ratio (OR) 1.67, 95% confidence interval (CI) 1.03–2.69; OR 2.75, 95% CI 1.75–4.33; OR 1.25, 95% CI 1.01–5.6, respectively]. Compared with subjects with neither gastric corpus atrophy nor gallstones, although subjects with gallstones alone were not associated with the presence of ESEM (OR 1.59, 95% CI 0.87–2.92), having both gastric corpus atrophy and gallstones was strongly associated with the presence of ESEM (OR 2.94, 95% CI 1.40–6.17).

Conclusions

The presence of gallstones was independently associated with the presence of ESEM in the Japanese outpatient population, suggesting a causal association of distal esophageal bile exposure with the development of ESEM. Further studies are needed to confirm our findings in cases with histologically confirmed Barrett’s esophagus.

Keywords

Barrett’s esophagus ESEM Gallstone Gastric mucosal atrophy 

References

  1. 1.
    Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510–3.PubMedGoogle Scholar
  2. 2.
    Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645–54.CrossRefPubMedGoogle Scholar
  4. 4.
    Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB. Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 2003;98:1627–33.PubMedGoogle Scholar
  5. 5.
    Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.CrossRefPubMedGoogle Scholar
  6. 6.
    Voutilainen M, Farkkila M, Juhola M, Nuorva K, Mauranen K, Mantynen T, et al. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group. Am J Gastroenterol. 1999;94:913–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20. quiz 1943.CrossRefPubMedGoogle Scholar
  8. 8.
    Richter JE. Importance of bile reflux in Barrett’s esophagus. Dig Dis. 2000;18:208–16.CrossRefPubMedGoogle Scholar
  9. 9.
    Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology. 1994;107:747–54.PubMedGoogle Scholar
  10. 10.
    Nehra D, Howell P, Williams CP, Pye JK, Beynon J. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut. 1999;44:598–602.PubMedCrossRefGoogle Scholar
  11. 11.
    Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett’s oesophagus. Gut. 2008;57:1056–64.CrossRefPubMedGoogle Scholar
  12. 12.
    Izbeki F, Rosztoczy AI, Yobuta JS, Roka R, Lonovics J, Wittmann T. Increased prevalence of gallstone disease and impaired gallbladder motility in patients with Barrett’s esophagus. Dig Dis Sci. 2008;53:2268–75.CrossRefPubMedGoogle Scholar
  13. 13.
    Johnston DE, Kaplan MM. Pathogenesis and treatment of gallstones. N Engl J Med. 1993;328:412–21.CrossRefPubMedGoogle Scholar
  14. 14.
    Shih WJ, Coupal JJ, Domstad PA, Ram MD, DeLand FH. Disorders of gallbladder function related to duodenogastric reflux in technetium-99 m DISIDA hepatobiliary scintigraphy. Clin Nucl Med. 1987;12:857–60.CrossRefPubMedGoogle Scholar
  15. 15.
    Kennedy NS, Campbell FC, Cullen PT, Sutton DG, Millar BW, Cuschieri A. Gallbladder function and fasting enterogastric bile reflux. Nucl Med Commun. 1989;10:193–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Svensson JO, Gelin J, Svanvik J. Gallstones, cholecystectomy, and duodenogastric reflux of bile acid. Scand J Gastroenterol. 1986;21:181–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Hongo M. Review article: Barrett’s oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004;20(Suppl 8):50–4.CrossRefPubMedGoogle Scholar
  18. 18.
    Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol. 2003;38(Suppl 15):25–30.PubMedGoogle Scholar
  19. 19.
    Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–97.CrossRefPubMedGoogle Scholar
  20. 20.
    Jones TF, Sharma P, Daaboul B, Cherian R, Mayo M, Topalovski M, et al. Yield of intestinal metaplasia in patients with suspected short-segment Barrett’s esophagus (SSBE) on repeat endoscopy. Dig Dis Sci. 2002;47:2108–11.CrossRefPubMedGoogle Scholar
  21. 21.
    Kim GH, Song GA, Kim TO, Jo HJ, Kim do H, Heo J, et al. Endoscopic grading of gastroesophageal flap valve and atrophic gastritis is helpful to predict gastroesophageal reflux. J Gastroenterol Hepatol. 2008;23:208–14.CrossRefPubMedGoogle Scholar
  22. 22.
    Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett’s esophagus. Am J Epidemiol. 2005;162:454–60.CrossRefPubMedGoogle Scholar
  23. 23.
    Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL. Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case–control study. Am J Gastroenterol. 2009;104:834–42.CrossRefPubMedGoogle Scholar
  24. 24.
    Park JJ, Kim JW, Kim HJ, Chung MG, Park SM, Baik GH, et al. The prevalence of and risk factors for Barrett esophagus in a Korean population: A Nationwide Multicenter Prospective Study. J Clin Gastroenterol. 2009 (Epub ahead of print).Google Scholar
  25. 25.
    Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer. 2007;109:668–74.CrossRefPubMedGoogle Scholar
  26. 26.
    Rubenstein JH, Dahlkemper A, Kao JY, Zhang M, Morgenstern H, McMahon L, et al. A pilot study of the association of low plasma adiponectin and Barrett’s esophagus. Am J Gastroenterol. 2008;103:1358–64.CrossRefPubMedGoogle Scholar
  27. 27.
    Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett’s length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol. 2002;97:1930–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Vianna A, Hayes PC, Moscoso G, Driver M, Portmann B, Westaby D, et al. Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology. 1987;93:876–89.PubMedGoogle Scholar
  30. 30.
    Kimura K, Satoh K, Ido K, Taniguchi Y, Takimoto T, Takemoto T. Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl. 1996;214:17–20. discussion 21–13.CrossRefPubMedGoogle Scholar
  31. 31.
    Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87–97.CrossRefGoogle Scholar
  32. 32.
    Ismail T, Bancewicz J, Barlow J. Endoscopic appearance of the gastroesophageal valve and competence of the cardia. Diagn Ther Endosc. 1996;2:147–50.CrossRefPubMedGoogle Scholar
  33. 33.
    Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.CrossRefPubMedGoogle Scholar
  34. 34.
    Brough WA, Taylor TV, Torrance HB. The surgical factors influencing duodenogastric reflux. Br J Surg. 1984;71:770–3.CrossRefPubMedGoogle Scholar
  35. 35.
    Johnson AG. Pyloric function and gall-stone dyspepsia. Br J Surg. 1972;59:449–54.CrossRefPubMedGoogle Scholar
  36. 36.
    Cabrol J, Navarro X, Simo-Deu J, Segura R. Evaluation of duodenogastric reflux in gallstone disease before and after simple cholecystectomy. Am J Surg. 1990;160:283–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Perdikis G, Wilson P, Hinder R, Redmond E, Wetscher G, Neary P, et al. Altered antroduodenal motility after cholecystectomy. Am J Surg. 1994;168:609–14. discussion 614–605.CrossRefPubMedGoogle Scholar
  38. 38.
    Lorusso D, Misciagna G, Mangini V, Messa C, Cavallini A, Caruso ML, et al. Duodenogastric reflux of bile acids, gastrin and parietal cells, and gastric acid secretion before and 6 months after cholecystectomy. Am J Surg. 1990;159:575–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Fein M, Bueter M, Sailer M, Fuchs KH. Effect of cholecystectomy on gastric and esophageal bile reflux in patients with upper gastrointestinal symptoms. Dig Dis Sci. 2008;53:1186–91.CrossRefPubMedGoogle Scholar
  40. 40.
    Freedman J, Ye W, Naslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121:548–53.CrossRefPubMedGoogle Scholar
  41. 41.
    Okita K, Amano Y, Takahashi Y, Mishima Y, Moriyama N, Ishimura N, et al. Barrett’s esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol. 2008;43:928–34.CrossRefPubMedGoogle Scholar
  42. 42.
    Cameron AJ. Barrett’s esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol. 1999;94:2054–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Weston AP, Sharma P, Mathur S, Banerjee S, Jafri AK, Cherian R, et al. Risk stratification of Barrett’s esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004;99:1657–66.CrossRefPubMedGoogle Scholar
  44. 44.
    Fujiwara Y, Higuchi K, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett’s epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol. 2003;38:533–9.PubMedGoogle Scholar
  45. 45.
    Moriichi K, Watari J, Das KM, Tanabe H, Fujiya M, Ashida T, et al. Effects of Helicobacter pylori infection on genetic instability, the aberrant CpG island methylation status and the cellular phenotype in Barrett’s esophagus in a Japanese population. Int J Cancer. 2009;124:1263–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, Bamford KB, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case–control study. Gut. 2008;57:734–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.CrossRefPubMedGoogle Scholar
  48. 48.
    Hofmann AF, Mysels KJ. Bile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH, and Ca2+ ions. J Lipid Res. 1992;33:617–26.PubMedGoogle Scholar
  49. 49.
    Zentler-Munro PL, Fine DR, Batten JC, Northfield TC. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis. Gut. 1985;26:892–901.CrossRefPubMedGoogle Scholar
  50. 50.
    Masci E, Testoni PA, Fanti L, Guslandi M, Zuin M, Tittobello A. Duodenogastric reflux: correlations among bile acid pattern, mucus secretion, and mucosal damage. Scand J Gastroenterol. 1987;22:308–12.CrossRefPubMedGoogle Scholar
  51. 51.
    Bechi P, Amorosi A, Mazzanti R, Dei R, Bianchi S, Mugnai L, et al. Reflux-related gastric mucosal injury is associated with increased mucosal histamine content in humans. Gastroenterology. 1993;104:1057–63.PubMedGoogle Scholar
  52. 52.
    Sobala GM, O’Connor HJ, Dewar EP, King RF, Axon AT, Dixon MF. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol. 1993;46:235–40.CrossRefPubMedGoogle Scholar
  53. 53.
    Dixon MF, Neville PM, Mapstone NP, Moayyedi P, Axon AT. Bile reflux gastritis and Barrett’s oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut. 2001;49:359–63.CrossRefPubMedGoogle Scholar
  54. 54.
    Mason RJ, Bremner CG. Gastritis in Barrett’s esophagus. World J Surg. 1995;19:96–100. discussion 100–101.CrossRefPubMedGoogle Scholar
  55. 55.
    Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3:1–10.CrossRefPubMedGoogle Scholar
  56. 56.
    Wood RK, Yang YX. Barrett’s esophagus in 2008: an update. Keio J Med. 2008;57:132–8.CrossRefPubMedGoogle Scholar
  57. 57.
    Iwasaki E, Suzuki H, Sugino Y, Iida T, Nishizawa T, Masaoka T, et al. Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome. J Gastroenterol Hepatol. 2008;23(Suppl 2):S216–21.CrossRefPubMedGoogle Scholar
  58. 58.
    Wang SN, Yeh YT, Yu ML, Dai CY, Chi WC, Chung WL, et al. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. Eur J Clin Invest. 2006;36:176–80.CrossRefPubMedGoogle Scholar
  59. 59.
    Wang SN, Yeh YT, Yu ML, Wang CL, Lee KT. Serum adiponectin levels in cholesterol and pigment cholelithiasis. Br J Surg. 2006;93:981–6.CrossRefPubMedGoogle Scholar
  60. 60.
    Friedenberg FK, Xanthopoulos M, Foster GD, Richter JE. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol. 2008;103:2111–22.CrossRefPubMedGoogle Scholar
  61. 61.
    de Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol. 2008;103:1349–54.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Juntaro Matsuzaki
    • 1
  • Hidekazu Suzuki
    • 1
  • Keiko Asakura
    • 2
  • Yoshimasa Saito
    • 1
  • Kenro Hirata
    • 1
  • Toru Takebayashi
    • 2
  • Toshifumi Hibi
    • 1
  1. 1.Division of Gastroenterology and Hepatology, Department of Internal MedicineKeio University School of MedicineShinjuku-kuJapan
  2. 2.Department of Preventive Medicine and Public HealthKeio University School of MedicineTokyoJapan

Personalised recommendations